NCT04542980 - Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

SARS-CoV 2 InfectionCovid19

Interventions

DIAGNOSTIC_TEST

SARS-CoV2 Autoantibody detection

Through the data collected from this study we hope to support the development of an ELISA assay for the detection of IgM and IgG autoantibodies produced in response to the presence of SARS-CoV2

Trial Locations (1)

72703

Namida Lab, Fayetteville